CannaNova Cannabinoid Film
Greensboro, NC, July 19, 2022 (GLOBE NEWSWIRE) — CannaNova Cannabinoid Film
CannaNova LLC today announced its formation to pursue the consumer cannabinoid space, employing DepoFilm™ technology. With DepoFilm™, CannaNova manufactures buccal consumer cannabinoid films.
CannaNova’s mission is to apply drug delivery principles and its second-generation oral film technology, DepoFilm™, to develop and market high performance cannabis consumables.
CannaNova CEO, Joseph Fuisz, commented: “CannaNova is using DepofIlm™ technology to address the key challenges that consumer cannabinoid products face today. These include: slow onset, low bioavailability, and inconsistent bioavailability from patient to patient. We also believe many adult consumers prefer a non-confectionary format.”
“We believe that rapid onset is particularly advantageous to allow adult consumers to enjoy consumer cannabinoids at the desired dose. Slow onset is fundamentally at odds with dose titration. Too frequently, consumers take extra edibles while mistakenly confusing slow onset for having taken too small of a dose.”
“Our hemp-derived products will be sold in eight count child-resistant blister cards.”
CannaNova CSO, Madhu Hariharan, commented: “We are excited to bring our next generation film technology, DepoFilm™, to the consumer cannabinoid category. Cannanova was formed to leverage our drug delivery expertise and patented technology for the consumer cannabinoid sector.”
“Consumers prefer our fast onset, mucoadhesive, buccal films over traditional means of consuming cannabinoids.”
“In addition to these advantages, DepoFilm™ technology also enables us to make compelling, highly brandable film shapes, reflecting the quality of our products for adult consumers.”
CannaNova plans to launch a limited test market under its DeltaFilm™ brand.
About CannaNova LLC:
CannaNova LLC develops, manufactures and markets cannabinoid consummables for adult consumers using patented DepoFilm™ technology. CannaNova is a private company with its headquarters in Greensboro, NC. www.cannanova.co
Attachment
CONTACT: jfuisz@fuisz.com
Access to an audience of over 19 million individuals monthly will expand national exposure, and…
NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…
AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…
Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…
Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…
Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…